ASTERIAS BIOTHERAPEUTICS, INC. filed this 10-Q on 20180509

Document Outline
Entire Document (1.6 MB)
Subdocument - 10-Q - 10-Q
  Page 1 - UNITED STATES
  Page 2 - PART I--FINANCIAL INFORMATION
  Page 3 - ASTERIAS BIOTHERAPEUTICS, INC.
  Page 4 - ASTERIAS BIOTHERAPEUTICS, INC.
  Page 5 - ASTERIAS BIOTHERAPEUTICS, INC.
  Page 6 - ASTERIAS BIOTHERAPEUTICS, INC.
  Page 7 - ASTERIAS BIOTHERAPEUTICS, INC.
  Page 8 - Grant income:
  Page 9 - Investments-Equity SecuritiesFair Value Measurement.
  Page 10 - Compensation Stock Compensation: Scope of Modification Accounting
  Page 11 - Investment in BioTime
  Page 12 - Common Stock Issuance
  Page 13 - Warrants classified as equity
  Page 14 - Development and Manufacturing Services Agreement
  Page 15 - Employment Contracts
  Page 16 - Services Agreement with Cell Therapy Catapult Services Limited
  Page 17 - Company Overview
  Page 18 - Recent Developments
  Page 19 - Critical Accounting Policies
  Page 20 - Operating Expenses
  Page 21 - Cash used in operations
  Page 22 - Contractual Obligations
  Page 23 - N/A
  Page 24 - N/A
Subdocument - EX-31.1 - EXHIBIT 31.1
  Page 1 - N/A
Subdocument - EX-31.2 - EXHIBIT 31.2
  Page 1 - N/A
Subdocument - EX-32.1 - EXHIBIT 32.1
  Page 1 - N/A